Arkolith/Insider Trading/CNTX/Form 4

Lehr Martin A.

Chief Executive Officer, DirectorContext Therapeutics Inc. (CNTX) · full profile →Form 4 · filed Oct 25, 2021
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 22, 2021Conversion(C)211K——263K
Oct 22, 2021Buy(P)10K$5.00$50K100K
Oct 22, 2021Option exercise(O)53K$7.14$376K53K
Oct 22, 2021Conversion(C)586K——850K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 22, 2021Conversion(C)211K——0
Oct 22, 2021Conversion(C)586K——0
Oct 22, 2021Option exercise(O)53K—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase
O
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-21-009609) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Context Therapeutics Inc.

Build

Ask your agent about CNTX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001179110-21-009609"
Ask your agent
Use Arkolith to summarize insider buying and selling at Context Therapeutics Inc.
over the last 90 days and cite the filings.